LTA anticorps (AA 45-59)
Aperçu rapide pour LTA anticorps (AA 45-59) (ABIN2625001)
Antigène
Voir toutes LTA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 45-59
-
Purification
- Immunogen affinity purified
-
Immunogène
- A synthetic peptide corresponding to a sequence at the N-terminus of human TNF beta(45-59aa AQTARQHPKMHLAHS).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid freeze-thaw cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- LTA (Lymphotoxin-alpha (LTA))
-
Autre désignation
- LTA / TNF beta
-
Classe de substances
- Chemical
-
Sujet
-
Name/Gene ID: LTA
Family: TNF
Synonyms: LTA, Lymphotoxin-alpha, LT-alpha, TNFSF1, TNF-beta, TNFB, Tumor necrosis factor beta, LT, TNF Beta -
ID gène
- 4049
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
Antigène
-